Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer-Reference-Cited by-同舟云学术

Xeroderma pigmentosum complementation group C single-nucleotide polymorphisms in the nucleotide excision repair pathway correlate with prolonged progression-free survival in advanced ovarian cancer

Published:2011-07-12 Issue:3 Volume:118 Page:689-697
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Fleming Nicole D.,Agadjanian Hasmik,Nassanian Hoorig,Miller Carl W.,Orsulic Sandra,Karlan Beth Y.,Walsh Christine S.

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.26329/fullpdf

Reference28 articles.

1. Standard treatment in advanced ovarian cancer in 2005: the state of the art;Bookman;Int J Gynecol Cancer.,2005

2. Relapsed ovarian cancer: challenges and management strategies for a chronic disease;Armstrong;Oncologist.,2002

3. Mechanism of action of cis-dichlorodiammine-platinum (II);Zwelling;Cancer Treat Rep.,1979

4. Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy;Reed;Proc Natl Acad Sci USA.,1987

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functional genetic variants of GEN1 predict overall survival of Chinese epithelial ovarian cancer patients;Journal of Translational Medicine;2024-06-18

2. Genetic variations in DNA excision repair pathway contribute to the chemosensitivity and prognosis of acute myeloid leukemia;Clinica Chimica Acta;2024-05

3. Molecular mechanisms of cisplatin resistance in ovarian cancer;Genes & Diseases;2023-08

4. Structural modeling and analyses of genetic variations in the human XPC nucleotide excision repair protein;Journal of Biomolecular Structure and Dynamics;2023-03-08

5. High expression of CETN2 is associated with platinum resistance and poor prognosis in epithelial ovarian cancer;Clinical and Translational Oncology;2022-12-17